BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2994988)

  • 1. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension.
    Franklin SS; Smith RD
    Nephron; 1986; 44 Suppl 1():73-82. PubMed ID: 3018602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension.
    Bauer JH; Jones LB
    Am J Kidney Dis; 1984 Jul; 4(1):55-62. PubMed ID: 6331157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function and hemodynamics during treatment with enalapril in primary hypertension.
    Bauer JH; Reams G; Gaddy P
    Nephron; 1986; 44 Suppl 1():83-6. PubMed ID: 3018603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enalapril alone, and in combination with hydrochlorothiazide, on renin-angiotensin-aldosterone, renal function, salt and water excretion, and body fluid composition.
    Bauer JH; Gaddy P
    Am J Kidney Dis; 1985 Oct; 6(4):222-32. PubMed ID: 2996332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP; Bauer JH
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the clinical pharmacology of enalapril.
    Davies RO; Gomez HJ; Irvin JD; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
    Frishman WH; Goldberger J; Sherman D
    J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
    J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral effects of long-term oral enalapril therapy.
    Reams GP; Bauer JH
    Am J Kidney Dis; 1986 May; 7(5):402-6. PubMed ID: 3010707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1998 Jul; 16(7):1023-9. PubMed ID: 9794744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
    Fernandez PG; Kim BK; Galway AB
    Pharmatherapeutica; 1984; 3(8):505-14. PubMed ID: 6322207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study.
    Chalmers JP; Wing LM; West MJ; Bune AJ; Elliott JM; Morris MJ; Cain MD; Graham JR; Southgate DO
    Aust N Z J Med; 1986 Aug; 16(4):475-80. PubMed ID: 3026294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.